https://pubmed.ncbi.nlm.nih.gov/36115844/
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple...
Oncogenic RAS mutations are common in multiple myeloma (MM), an incurable malignancy of plasma cells. However, the mechanisms of pathogenic RAS signaling in...